Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1052705-85-7

4-(cyclohex-1-en-1-yl)pyridin-3-amine is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1052705-85-7 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 1052705-85-7 Structure

  • Basic information

    1. Product Name: 4-(cyclohex-1-en-1-yl)pyridin-3-amine
    2. Synonyms: 4-(cyclohex-1-en-1-yl)pyridin-3-amine
    3. CAS NO:1052705-85-7
    4. Molecular Formula:
    5. Molecular Weight: 174.246
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 1052705-85-7.mol

  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: N/A
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: 4-(cyclohex-1-en-1-yl)pyridin-3-amine(CAS DataBase Reference)
    10. NIST Chemistry Reference: 4-(cyclohex-1-en-1-yl)pyridin-3-amine(1052705-85-7)
    11. EPA Substance Registry System: 4-(cyclohex-1-en-1-yl)pyridin-3-amine(1052705-85-7)

  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 1052705-85-7(Hazardous Substances Data)

1052705-85-7 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1052705-85-7 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,5,2,7,0 and 5 respectively; the second part has 2 digits, 8 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 1052705-85:
(9*1)+(8*0)+(7*5)+(6*2)+(5*7)+(4*0)+(3*5)+(2*8)+(1*5)=127
127 % 10 = 7
So 1052705-85-7 is a valid CAS Registry Number.

1052705-85-7Downstream Products

1052705-85-7Relevant articles and documents

GSK-3 INHIBITORS

-

Page/Page column 124, (2015/05/26)

The disclosure generally relates to compounds of formula I, including their salts, as well as compositions and methods of using the compounds to treat disorders associated with GSK-3.

PIM KINASE INHIBITORS AND METHODS OF THEIR USE

-

, (2008/12/07)

New compounds, compositions and methods of inhibition of kinase activity associated with tumorigenesis in a human or animal subject are provided. In certain embodiments, the compounds and compositions are effective to inhibit the activity of at least one serine/threonine kinase or receptor tyrosine kinase. The new compounds and compositions may be used either alone or in combination with at least one additional agent for the treatment of a serine/threonine kinase- or receptor tyrosine kinase- mediated disorder, such as cancer.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1052705-85-7